I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
The Irreversible FLT3 Inhibitor FF-10101 Is Active Against ..:
Ferng, Timothy T
;
Terada, Daisuke
;
Ando, Makoto
...
qt00z867b3. , 2022
Link:
https://escholarship.org/uc/item/00z867b3
RT Journal T1
The Irreversible FLT3 Inhibitor FF-10101 Is Active Against a Diversity of FLT3 Inhibitor Resistance MechanismsFF-10101 Overcomes FLT3 TKI Resistance Mechanisms
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt00z867b3&Exemplar=1&LAN=DE A1 Ferng, Timothy T A1 Terada, Daisuke A1 Ando, Makoto A1 Tarver, Theodore C A1 Chaudhary, Fihr A1 Lin, Kimberly C A1 Logan, Aaron C A1 Smith, Catherine C PB eScholarship, University of California YR 2022 K1 Biomedical and Clinical Sciences K1 Clinical Sciences K1 Oncology and Carcinogenesis K1 Hematology K1 Pediatric K1 Cancer K1 Childhood Leukemia K1 Clinical Research K1 Pediatric Cancer K1 Rare Diseases K1 Evaluation of treatments and therapeutic interventions K1 5.1 Pharmaceuticals K1 6.1 Pharmaceuticals K1 Development of treatments and therapeutic interventions K1 Amides K1 Cell Line K1 Tumor K1 Drug Resistance K1 Neoplasm K1 Humans K1 Leukemia K1 Myeloid K1 Acute K1 Mutation K1 Protein Kinase Inhibitors K1 Pyrimidines K1 Tumor Microenvironment K1 fms-Like Tyrosine Kinase 3 K1 Pharmacology and Pharmaceutical Sciences K1 Oncology & Carcinogenesis K1 Biochemistry and cell biology JF qt00z867b3 LK http://dx.doi.org/https://escholarship.org/uc/item/00z867b3 DO https://escholarship.org/uc/item/00z867b3 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)